This inventor holds 9 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignees: Evolva Sa, Evola Sa, Fluxome Sciences A/s. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Malmø, SE (2013)
- Malmö, SE (2013 - 2014)
- Malmo, SE (2015 - 2017)
Company Filing History:
Years Active: 2013-2017
Title: The Innovative Contributions of Michael Katz
Introduction
Michael Katz is a prominent inventor based in Malmo, Sweden, known for his significant contributions to biotechnology. With a total of nine patents to his name, Katz has made remarkable advancements in the production of valuable metabolites through engineered microorganisms. His work has implications for various industries, including pharmaceuticals and agriculture.
Latest Patents
Katz's latest patents include groundbreaking technologies such as "Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof." This patent describes a recombinant microorganism that produces resveratrol through a complex biochemical pathway involving several enzymes. Another notable patent is focused on the "Production of metabolites," which details a recombinant microorganism that excretes stilbenoid metabolite products into the culture medium. This innovation enhances the efficiency of metabolite production, showcasing Katz's expertise in metabolic engineering.
Career Highlights
Throughout his career, Michael Katz has worked with notable companies such as Evolva SA and Fluxome Sciences A/S. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of biotechnological applications. Katz's work is characterized by a strong focus on the genetic modification of microorganisms to optimize the production of valuable compounds.
Collaborations
Katz has collaborated with esteemed colleagues, including Hans Peter Smits and Jochen Förster. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their collective work in the field of biotechnology.
Conclusion
Michael Katz's innovative contributions to biotechnology through his patents and collaborations have positioned him as a leading figure in the field. His work continues to influence the development of new technologies that harness the potential of engineered microorganisms for various applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile